These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 6691776

  • 1. Plasma and urinary catecholamines and their metabolites in chronic renal failure.
    Darwish R, Elias AN, Vaziri ND, Pahl M, Powers D, Stokes JD.
    Arch Intern Med; 1984 Jan; 144(1):69-71. PubMed ID: 6691776
    [Abstract] [Full Text] [Related]

  • 2. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.
    Bravo EL, Tarazi RC, Gifford RW, Stewart BH.
    N Engl J Med; 1979 Sep 27; 301(13):682-6. PubMed ID: 481462
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic Acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma.
    Boyle JG, Davidson DF, Perry CG, Connell JM.
    J Clin Endocrinol Metab; 2007 Dec 27; 92(12):4602-8. PubMed ID: 17635948
    [Abstract] [Full Text] [Related]

  • 5. Effect of furosemide on urinary excretion of 4-hydroxy-3-methoxymandelic acid (VMA).
    Bursztyn M, Gutman A.
    Isr J Med Sci; 1985 Sep 27; 21(9):742-4. PubMed ID: 4055336
    [Abstract] [Full Text] [Related]

  • 6. [Catecholamines and their derivatives in the study of pheochromocytoma].
    Zoghbi F, Landault C, Salmon N, Legrand JC.
    Ann Med Interne (Paris); 1983 Sep 27; 134(3):230-2. PubMed ID: 6625416
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Biochemical diagnosis of pheochromocytoma and neuroblastomas].
    Candito M, Billaud E, Chauffert M, Cottet-Emard JM, Desmoulin D, Garnier JP, Greffe J, Hirth C, Jacob N, Millot F, Nignan A, Patricot MC, Peyrin L, Plouin PF.
    Ann Biol Clin (Paris); 2002 Sep 27; 60(1):15-36. PubMed ID: 11830391
    [Abstract] [Full Text] [Related]

  • 9. The diagnosis of pheochromocytoma. Overnight excretion of catecholamine metabolites.
    Sullivan JM, Solomon HS.
    JAMA; 1975 Feb 10; 231(6):618-9. PubMed ID: 1172846
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic difficulties associated with phaeochromocytoma--4 case illustrations.
    Tan KE, Fok AC, Eng PH, Khoo DH.
    Singapore Med J; 1997 Nov 10; 38(11):493-6. PubMed ID: 9550913
    [Abstract] [Full Text] [Related]

  • 11. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N, Nagasaka N.
    ASDC J Dent Child; 1996 Nov 10; 63(2):118-22. PubMed ID: 8708120
    [Abstract] [Full Text] [Related]

  • 12. [Biological diagnosis of pheochromocytoma: impact of technological improvement].
    Peyrin L, Mornex R.
    Ann Biol Clin (Paris); 1993 Nov 10; 51(10-11):835-65. PubMed ID: 8210060
    [Abstract] [Full Text] [Related]

  • 13. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
    Davidson DF, Grosset K, Grosset D.
    Ann Clin Biochem; 2007 Jul 10; 44(Pt 4):364-8. PubMed ID: 17594783
    [Abstract] [Full Text] [Related]

  • 14. [Strategy for the biochemical study of pheochromocytoma].
    Peyrin L.
    Ann Med Interne (Paris); 1983 Jul 10; 134(3):235-7. PubMed ID: 6625418
    [Abstract] [Full Text] [Related]

  • 15. The biochemical diagnosis, localization and follow up of phaeochromocytoma: the role of plasma and urinary catecholamine measurements.
    Jones DH, Reid JL, Hamilton CA, Allison DJ, Welbourn RB, Dollery CT.
    Q J Med; 1980 Jul 10; 49(195):341-61. PubMed ID: 7465766
    [Abstract] [Full Text] [Related]

  • 16. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
    Alonso R, Gibson CJ, Wurtman RJ, Agharanya JC, Prieto L.
    Biol Psychiatry; 1982 Jul 10; 17(7):781-90. PubMed ID: 7115832
    [Abstract] [Full Text] [Related]

  • 17. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
    Kévorkian JP, Michel C, Hofmann U, Jacqz-Aigrain E, Kroemer HK, Peraldi MN, Eichelbaum M, Jaillon P, Funck-Brentano C.
    Clin Pharmacol Ther; 1996 May 10; 59(5):583-92. PubMed ID: 8646830
    [Abstract] [Full Text] [Related]

  • 18. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr 10; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K, Kubo M, Masuda K, Tokumoto M, Hirakawa M, Ikeda H, Matsui R, Matsuo D, Fukuda K, Kanai H, Hirakata H, Iida M.
    Clin Exp Nephrol; 2003 Dec 10; 7(4):279-83. PubMed ID: 14712357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.